Bullish & Foolish
Full VTAK fundamentals All 466 on the Survival Watch

VTAKCatheter Precision, Inc.

Is Catheter Precision struggling financially?

Yes, by its own account. Catheter Precision told the SEC on 18 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$3.0M
Source filing
10-Q 18 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 0months

    If the burn speeds up

    Empty by Jun 2026

  • 1month

    If it eases off

    Empty by Jul 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$643K

÷

Cash burned over the last 12 months

$16.8M

What Catheter Precision told the SEC

…of approximately $ 3.2 million after deducting transaction costs of approximately $ 0.3 million. Based on the Company's liquidity resources, there is substantial doubt about the Company’s ability to continue as a going concern within 12 months from the date of issuance of the unaudited condensed consolidated financial statements. The accompanying unaudited condensed consolidated financial statements have…

Catheter Precision, Inc., Form 10-Q, filed 18 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Debt pressure is material Debt is large against the cash on hand while the business generates little to service it, which puts lenders ahead of shareholders in the queue.

Other Biotech/Pharma companies that filed the doubt